O6-Benzylguanine Enhances the In Vitro Immunotoxic Activity of Temozolomide on Natural or Antigen-Dependent Immunity

作者: Enzo Bonmassar , Elena Pagani , Stefania D'Atri , Ester Alvino , Rita Pepponi

DOI:

关键词:

摘要: Temozolomide (TMZ) is a new cytotoxic triazene compound of clinical interest that able to generate methyl adducts at the O 6 -guanine DNA, which can be repaired by -alkylguanine-DNA alkyltransferase (OGAT). It was previously found compounds are highly immunosuppressive in mice. In present study, we investigate whether TMZ could affect immune functions human competent cells and methylation involved activity drug. Mononuclear (MNCs) obtained from peripheral blood healthy donors were tested for OGAT treated with alone or combined inhibitor -benzylguanine. Control drug-treated MNCs then assayed natural killer ability proliferate effector response interleukin-2 allogeneic MT-2 tumor cells. The results show inhibited both proliferation induction lytic Moreover, an inverse correlation between their sensitivity TMZ. involvement effects further confirmed finding -benzylguanine increased On other hand, only moderately affected TMZ, no relationship observed levels These data suggest patients tumors who undergoing treatment, drug may impair responses involving cell proliferation, depending on MNCs, potentiate this activity.

参考文章(37)
Anthony E. Pegg, M. Eileen Dolan, Robert C. Moschel, Christine Mummert, R. Brian Mitchell, Effect of O6-Benzylguanine Analogues on Sensitivity of Human Tumor Cells to the Cytotoxic Effects of Alkylating Agents Cancer Research. ,vol. 51, pp. 3367- 3372 ,(1991)
Gilberti S, Bonmassar E, Graziani G, Tentori L, D'Atri S, Lacal Pm, Triazene compounds induce apoptosis in O6-alkylguanine-DNA alkyltransferase deficient leukemia cell lines. Leukemia. ,vol. 9, pp. 1888- 1895 ,(1995)
Lili Liu, Sanford Markowitz, Stanton L. Gerson, Mismatch repair mutations override alkyltransferase in conferring resistance to temozolomide but not to 1,3-bis(2-chloroethyl)nitrosourea. Cancer Research. ,vol. 56, pp. 5375- 5379 ,(1996)
A E Pegg, M E Dolan, O6-benzylguanine and its role in chemotherapy. Clinical Cancer Research. ,vol. 3, pp. 837- 847 ,(1997)
N M Bleehen, E S Newlands, S M Lee, N Thatcher, P Selby, A H Calvert, G J Rustin, M Brampton, M F Stevens, Cancer Research Campaign phase II trial of temozolomide in metastatic melanoma. Journal of Clinical Oncology. ,vol. 13, pp. 910- 913 ,(1995) , 10.1200/JCO.1995.13.4.910
Christian Fizames, François Lavelle, John A. Slack, David Chubb, John A. Hickman, Robert Stone, Simon P. Langdon, Colin Goddard, Ghousia Baig, Neil W. Gibson, Edward Lunt, Christopher Newton, Malcolm F. G. Stevens, Lisa Vickers, Antitumor Activity and Pharmacokinetics in Mice of 8-Carbamoyl-3-methyl-imidazo[5,1-d]-1,2,3,5-tetrazin-4(3H)-one (CCRG 81045; M & B 39831), a Novel Drug with Potential as an Alternative to Dacarbazine Cancer Research. ,vol. 47, pp. 5846- 5852 ,(1987)
Stefania D’Atri, Lucio Tentori, Pedro Miguel Lacal, Grazia Graziani, Elena Pagani, Elena Benincasa, Giovanna Zambruno, Enzo Bonmassar, Josef Jiricny, INVOLVEMENT OF THE MISMATCH REPAIR SYSTEM IN TEMOZOLOMIDE-INDUCED APOPTOSIS Molecular Pharmacology. ,vol. 54, pp. 334- 341 ,(1998) , 10.1124/MOL.54.2.334
Graham L. Cohen, Carla I. Falkson, Current Treatment Options for Malignant Melanoma Drugs. ,vol. 55, pp. 791- 799 ,(1998) , 10.2165/00003495-199855060-00006